Researchers & Healthcare Professionals

www.lls.org/researchershealthcareprofessionals

Did you know?

LLS Therapy Acceleration Program partner, Avila Therapeutics, has initiated a phase 1 study of AVL-292, a targeted covalent drug for B cell cancers and autoimmune diseases.

Specialized Center of Research Program

Interdisciplinary research, collaboration and teamwork in the effort to cure and better treat blood cancers is what's behind The Leukemia & Lymphoma Society's (LLS's) Specialized Center of Research Program.

The Marshall A. Lichtman Specialized Center of Research (SCOR) program is our most ambitious research opportunity to date. This innovative program supports interdisciplinary research across at least three independent research projects that are integrated and supported by scientific core laboratories.

Members of our SCOR teams include some of the brightest medical specialists in the field of leukemia, lymphoma and myeloma research--brought together to be part of a highly organized and inspired team approach to speed the discovery of new drugs and curative treatment.

We invite you to be part of an innovative, interdisciplinary research team and a catalyst in helping to develop groundbreaking treatment for leukemia, lymphoma and myeloma.

Effective Award Year 2013

Apply for a grant

SCOR Guidelines & Instructions (Revised)

SCOR Revised Policies & Procedures (Revised)

Award

Not to exceed $1.25 million, which includes direct and indirect costs. Aggregate costs over five years cannot exceed $6.25 million. Direct costs, if justified by the aggregate budget, may be up to $1.042 million per year. The indirect or institutional costs cannot exceed 20 percent of the direct costs per year.

Application Renewal

SCOR grantees may apply for additional funding after five years depending on progress shown. These applications for additional funding will compete with all applications received by LLS for that academic year.

Deadline

Letter of intent due November 1

Full application If the SCOR committee approves your LOI, you will be invited to submit a full application. You'll receive notification to submit your proposal by December 31. You must then submit your application by March 15, 2013.

How to Apply

LLS uses proposalCENTRAL for electronic preliminary and full application submission.

If you submitted a proposal and developed a profile with LLS in the past, you (and your institution) still need to complete a new profile in proposalCENTRAL. If you have any technical difficulties with proposalCENTRAL, contact their customer support team.

Need More Information?

Contact:

Director of Research Administration

The Leukemia & Lymphoma Society

1311 Mamaroneck Ave.

White Plains, NY 10605

(914) 821-8301, (914) 821-8290

researchprograms@lls.org

See the 2012 SCOR review panel members.

last updated on Monday, August 13, 2012
btn_sharethis

Why LLS?

Your gift will be used to fund vital research and support our patient and community services.

Questions? Contact us.

Publications

Publications

A free resource provided by the National Institutes of Health - access more than 20 million biomedical literature citations.

Learn More